Novel Imaging Technique called 68Gallium DOTATATE PET/CT
In the United States, it is estimated that in 2021 approximately 44,000 people will receive a new diagnosis of thyroid cancer. Doctors at the National Institutes of Health (NIH) are conducting a research study for thyroid cancer. Researchers are using a novel imaging technique called 68Gallium DOTATATE PET/CT, which has been proven safe and effective in patients with other tumors – neuroendocrine tumors.
Who Can Participate:
- Volunteers 18 years or older.
- Diagnosed with thyroid cancer that has spread outside the thyroid.
- Able to provide informed consent.
Study Details:
- You will have a medical interview, physical exam.
- CT scan of the neck, chest, abdomen, and pelvis.
- Participation will last for approximately 3 months.
All tests and procedures are provided at no cost. Travel and lodging may be provided.
The NIH Clinical Center, America's Research Hospital, is located in Bethesda, MD, on the Metro Red Line (Medical Center stop).
For More Information:
NIH Clinical Center Office of Patient Recruitment
800-411-111
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online
Refer to NIH study # 000079-DK
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)